Science Explorer Interactive view Map
Company · Warsaw · Poland

CRE Consulting (Poland)

Research works
83
▼ 66% vs 2013–17
Citations
443
5.4 per fractional work
Top-10% rate
16.8%
record average 16.5%
Open access
42%
world 28%

Not ranked overall: CRE Consulting (Poland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.18× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.30× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 4.86× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 0.77× its world share, 0 worksPharmacology, Toxico…Energy: 4.00× its world share, 0 worksEnergyEngineering: 0.61× its world share, 1 worksEngineeringEnvironmental Science: 1.83× its world share, 1 worksEnvironmental ScienceMathematics: 2.77× its world share, 0 worksMathematicsPhysics and Astronomy: 0.37× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.46× its world share, 0 worksHealth ProfessionsMedicine: 1.98× its world share, 5 worksMedicineBusiness, Management and Accounting: 2.91× its world share, 1 worksBusiness, Management…Decision Sciences: 5.91× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 4.00× its world share, 1 worksEconomics, Econometr…Psychology: 0.40× its world share, 0 worksPsychologySocial Sciences: 0.17× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Decision Sciences, 5.9×. Every wedge is a field page.

Which keywords describe research at CRE Consulting (Poland)?

By fractional works in all years, weighted toward what it does more of than the world: Immune Response, Glycemic Control, Insulin Therapy, Quality of Life, Diabetes, Antiviral Therapy, Liver Disease and Cost-effectiveness Analysis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Quality of Life6▲ 5.9×7 topics
  2. Epidemiology6▲ 1.90×22 topics
  3. Immune Response6▲ 12×5 topics
  4. Glycemic Control6▲ 51×3 topics
  5. Insulin Therapy6▲ 64×3 topics
  6. Diabetes5▲ 12×6 topics
  7. Antiviral Therapy5▲ 40×2 topics
  8. Cost-effectiveness Analysis5▲ 78×1 topic
  9. Health Utility Measures5▲ 78×1 topic
  10. Liver Disease5▲ 44×2 topics
  11. Rituximab4▲ 33×2 topics
  12. Treatment4▲ 3.8×5 topics
  13. Prognostic Factors4▲ 10×2 topics
  14. Chronic Lymphocytic Leukemia4▲ 91×1 topic
  15. Genomic Aberrations4▲ 91×1 topic
  16. Cardiovascular Disease4▲ 3.9×7 topics
  17. Guidelines4▲ 9.2×8 topics
  18. Clinical Guidelines4▲ 13×4 topics
  19. Risk Factors4▲ 4.1×7 topics
  20. Genetic Variation3▲ 13×5 topics
  21. Global Burden3▲ 7.5×4 topics
  22. Type 2 Diabetes3▲ 21×4 topics
  23. Complications3▲ 7.4×4 topics
  24. Hepatitis C Virus3▲ 70×1 topic
  25. Hepatocellular Carcinoma3▲ 17×2 topics
  26. Ribavirin3▲ 70×1 topic
  27. Type 1 Diabetes3▲ 40×2 topics
  28. Heart Failure3▲ 7.9×5 topics
  29. Pharmaceutical Industry3▲ 84×2 topics
  30. Atherosclerosis3▲ 8.9×3 topics
  31. Cardiovascular Outcomes3▲ 76×1 topic
  32. Glucose Control3▲ 76×1 topic
  33. Health Outcomes2▲ 13×3 topics
  34. Continuous Glucose Monitoring2▲ 65×1 topic
  35. Drug Development Costs2▲ 117×1 topic
  36. Generic Drugs2▲ 117×1 topic
  37. Hypoglycemia2▲ 65×1 topic
  38. Revascularization2▲ 20×3 topics
  39. Life Expectancy2▲ 44×2 topics
  40. Chronic Hepatitis B2▲ 47×1 topic

Which research topics does CRE Consulting (Poland) publish most on?

By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Big Data and Business Intelligence, Lymphoma Diagnosis and Treatment and Advanced Breast Cancer Therapies.

  1. 1 Chronic Lymphocytic Leukemia Research Genetics 2 works
  2. 2 Big Data and Business Intelligence Management Information Systems 1 works
  3. 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  4. 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  6. 6 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
  7. 7 Global Cancer Incidence and Screening Oncology 0 works
  8. 8 Design Education and Practice Mechanical Engineering 0 works
  9. 9 Atmospheric aerosols and clouds Global and Planetary Change 0 works
  10. 10 BIM and Construction Integration Building and Construction 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.9%not open58.1%

World: 28% of research is openly available.

with international co-authors20.7%domestic only79.3%

World: 19% is written across borders.

How has CRE Consulting (Poland)'s research output changed?

Output in 2018–2022 was 66% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Warsaw

All research institutions in Warsaw

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.